RECQL and breast cancer: The allelic variant c.1667_1667+3delAGTA in the RECQL gene is described as a founder mutation in the studied population from Poland, with a frequency of 0.23% in the group of unselected breast cancer cases and 0.04% in the control group with OR = 5.4 [5].